Samjin Pharmaceuticals Market Cap

Samjin Pharmaceuticals has a market cap or net worth of 228.48 billion as of June 6, 2025. Its market cap has decreased by -10.17% in one year.

Market Cap

228.48B

Enterprise Value

n/a

Revenue

274.03B

Ranking

n/a

PE Ratio

10.79

Stock Price

18,640.00

Market Cap Chart

Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 228.48B, an increase of 684.64%. That is a compound annual growth rate of 7.16%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2025	228.48B	3.10%
Dec 30, 2024	221.61B	-19.69%
Dec 28, 2023	275.94B	-19.80%
Dec 29, 2022	344.07B	5.06%
Dec 30, 2021	327.51B	-3.49%
Dec 30, 2020	339.34B	9.22%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.53T
Celltrion	34.68T
ALTEOGEN	19.69T
Yuhan	7,778.15B
SK Biopharmaceuticals	7,079.52B
HLB Co., Ltd.	6,860.00B
PharmaResearch	4,976.64B
LigaChem Biosciences	3,893.48B

Market Cap Rankings